PMC:7405836 / 119703-119880 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7405836","sourcedb":"PMC","sourceid":"7405836","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7405836","text":"Therapeutic strategies involving the use of specific antibodies or compounds that neutralize cytokines and their receptors will help to restrain the host inflammatory responses.","tracks":[{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T57","span":{"begin":93,"end":102},"obj":"Body_part"}],"attributes":[{"id":"A57","pred":"fma_id","subj":"T57","obj":"http://purl.org/sig/ont/fma/fma84050"},{"subj":"T57","pred":"source","obj":"LitCovid-PD-FMA-UBERON"}]},{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T30","span":{"begin":154,"end":176},"obj":"http://purl.obolibrary.org/obo/GO_0006954"}],"attributes":[{"subj":"T30","pred":"source","obj":"LitCovid-PD-GO-BP"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T807","span":{"begin":0,"end":177},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T807","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-FMA-UBERON","color":"#beec93","default":true},{"id":"LitCovid-PD-GO-BP","color":"#ec93d8"},{"id":"LitCovid-sentences","color":"#93ece5"}]}]}}